Suppression of nascent DNA degradation has emerged as an essential role of the BRCA pathway in genome protection. In BRCA-deficient cells, the MRE11 nuclease is responsible for both resection of reversed replication forks, and accumulation of single stranded DNA gaps behind forks. Here, we show that the mono-ADP-ribosyltransferase PARP14 is a critical co-factor of MRE11. PARP14 is recruited to nascent DNA upon replication stress in BRCA-deficient cells, and through its catalytic activity, mediates the engagement of MRE11. Loss or inhibition of PARP14 suppresses MRE11-mediated fork degradation and gap accumulation, and promotes genome stability and chemoresistance of BRCA-deficient cells. Moreover, we show that the KU complex binds reversed forks and protects them against EXO1-catalyzed degradation. KU recruits the PARP14-MRE11 complex, which initiates partial resection to release KU and allow long-range resection by EXO1. Our work identifies a multistep process of nascent DNA processing at stalled replication forks in BRCA-deficient cells.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420157 | PMC |
| http://dx.doi.org/10.1038/s41467-022-32756-5 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
CAF-1 promotes efficient PrimPol recruitment to nascent DNA for single-stranded DNA gap formation.
Nucleic Acids Res
December 2024
Department of Biochemistry and Molecular Biology, The Pennsylvania State University College of Medicine, Hershey, PA 17033, USA.
Article Synopsis
- - The accumulation of single-stranded DNA (ssDNA) gaps at replication forks may influence how sensitive certain tumors are to chemotherapy, particularly those deficient in homologous recombination (HR), since these ssDNA gaps can turn into harmful double-stranded DNA breaks.
- - The study highlights the crucial role of the histone chaperone CAF-1, not just in maintaining stalled replication forks, but also in promoting ssDNA gap formation via its interaction with PrimPol, an enzyme that aids in managing replication stress.
- - Findings suggest that the loss of CAF-1 or ASF1A in HR-deficient cells leads to increased chemoresistance due to a reduction in ssDNA gaps, pointing to a novel function of CAF-
PARG inhibitor sensitivity correlates with accumulation of single-stranded DNA gaps in preclinical models of ovarian cancer.
Proc Natl Acad Sci U S A
November 2024
Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Boston, MA 02215.
Article Synopsis
- PARG (poly (ADP-ribose) glycohydrolase) is an enzyme that helps repair DNA by removing poly (ADP-ribose), and inhibiting it can lead to increased DNA damage and sensitize cancer cells to treatments.
- Inhibiting PARG leads to the buildup of single-stranded DNA gaps (ssGAPs) during DNA replication, similar to the effects of PARP inhibitors, particularly in cancer cells that are sensitive to treatment.
- Research shows that treatment with PARG inhibitors (PARGi) not only affects homologous recombination-deficient cancer cells but also has potential effectiveness in certain homologous recombination-proficient tumors, suggesting patient-derived organoids could be key
Positioning loss of PARP1 activity as the central toxic event in BRCA-deficient cancer.
DNA Repair (Amst)
December 2024
Department of Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA. Electronic address:
The mechanisms by which poly(ADP-ribose) polymerase 1 (PARP1) inhibitors (PARPi)s inflict replication stress and/or DNA damage are potentially numerous. PARPi toxicity could derive from loss of its catalytic activity and/or its physical trapping of PARP1 onto DNA that perturbs not only PARP1 function in DNA repair and DNA replication, but also obstructs compensating pathways. The combined disruption of PARP1 with either of the hereditary breast and ovarian cancer genes, BRCA1 or BRCA2 (BRCA), results in synthetic lethality.
View Article and Find Full Text PDFPARP10 promotes the repair of nascent strand DNA gaps through RAD18 mediated translesion synthesis.
Nat Commun
July 2024
Department of Biochemistry and Molecular Biology, The Pennsylvania State University College of Medicine, Hershey, PA, 17033, USA.
Replication stress compromises genomic integrity. Fork blocking lesions such as those induced by cisplatin and other chemotherapeutic agents arrest replication forks. Repriming downstream of these lesions represents an important mechanism of replication restart, however the single stranded DNA (ssDNA) gaps left behind, unless efficiently filled, can serve as entry point for nucleases.
View Article and Find Full Text PDFHow to sensitize glioblastomas to temozolomide chemotherapy: a gap-centered view.
Front Cell Dev Biol
July 2024
Center for Genomic Integrity, Institute for Basic Science, Ulsan, Republic of Korea.
Temozolomide (TMZ) is a methylating agent used as the first-line drug in the chemotherapy of glioblastomas. However, cancer cells eventually acquire resistance, necessitating the development of TMZ-potentiating therapy agents. TMZ induces several DNA base adducts, including -meG, 3-meA, and 7-meG.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!